Share-Based Compensation (Tables)

12 Months Ended

Dec. 31, 2023

Share-Based Payment Arrangement [Abstract]

Schedule of Income Tax Benefit Recognized for our Share-Based Compensation Arrangements

Compensation cost included in income from continuing operations, primarily selling, general and administrative expense, and the income tax benefit recognized for our share-based compensation arrangements is included below:

 

	Years Ended December 31,
	2023		2022		2021
	(In thousands)
Total share-based compensation cost	$	21,024	$	23,454	$	22,627
Income tax benefit	5,004		5,582		5,385

Schedule of Fair Values for SARs and Stock Options Estimated on Grant Date Using Black-Scholes-Merton Option-Pricing Formula Which Incorporates Assumptions

	Years Ended December 31,
	2023			2022			2021
	(In thousands, except weighted average fair value and assumptions)
Weighted-average fair value of SARs granted	$	39.44		$	21.85		$	18.30
Total intrinsic value of SARs exercised	12,229			4,384			1,581
Tax benefit from SARs exercised	660			678			327
Weighted-average fair value of restricted stock units granted	95.32			61.61			51.76
Total fair value of restricted stock units vested	19,821			16,830			12,623
Expected volatility	43.45		%	43.00		%	45.34		%
Expected term (in years)	5.7			5.6			5.7
Risk-free rate	4.26		%	1.89		%	0.70		%
Dividend yield	0.23		%	0.37		%	0.44		%

Schedule of Share Based Compensation Activity

	SARs						Restricted Stock Units
	Number	Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Term	Aggregate Intrinsic Value		Number	Weighted- Average Grant-Date Fair Value
	(In thousands, except exercise prices, fair values, and contractual terms)
Outstanding at January 1, 2023	958	$	64.13	4.8	$	10,017	897	$	54.59
Granted	115	85.77					410	95.32
Exercised or converted	(576)	67.85					(398)	49.77
Forfeited or expired	(84)	63.97					(210)	59.98
Outstanding at December 31, 2023	413	$	64.97	6.6	$	6,220	699	$	71.95
Exercisable or convertible at December 31, 2023	213	$	61.16	4.8	$	3,684